Biotech Values

[pharmaclown35]

what do you think about Avanir (NASDAQ:AVNR). they're developing this drug to treat this really rare indication called PBA. basically it's uncontrollable laughing. the drug was bounced around a few times at the FDA. i think it got 2 complete response letters from the FDA.

a lot of ppl i've spoken with seem to be interested in the company. but this indication, PBA - first line treatment is still cheap anti-depressants.

what do you think the chances are that someone like BIIB would acquire them for their compound and expand it maybe to other neurological problems. maybe BIIB less likely, but a speciality pharma comapny involved in pain. like diabetic neuropathy or something.

their shares have been up 40% in the last couple of weeks. thanks.